Cholesterol embolization syndrome induced by thrombolytic therapy.

Cholesterol embolization syndrome (CES) induced by thrombolytic therapy is a rare syndrome with a high incidence of morbidity and mortality. The variability in clinical presentations may cause a delay in diagnosis of CES. This article presents a comprehensive review of the English literature from January 1980 to December 2007 identifying all published case reports of CES induced by thrombolytic therapy.

Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic kidney disease: a different spectrum of calciphylaxis.

Calciphylaxis is characterized by the development of spontaneous skin ulcers that often progress to deep tissue necrosis. We present a case of calciphylaxis in a patient with chronic kidney disease (CKD) prior to the initiation of dialysis. We conclude that calciphylaxis should be considered in the differential diagnosis of skin ulcerations in patients with any degree of CKD.

Cholesterol emboli-induced renal failure and gastric ulcer after thrombolytic therapy.

Cholesterol embolization syndrome is a rare but devastating complication of thrombolysis. Clinical presentations are variable, which has resulted in labeling this syndrome as the great masquerader. Almost every organ in the body may be affected, but the syndrome commonly involves the kidney, skin, central nervous system, and gastrointestinal tract.